Figure 3

Morphomolecular progression of WLS expression in serous ovarian cancer, from borderline (a), low-grade (b), high-grade (c), and metastatic (d) serous carcinomas (all at magnification × 40).

Morphomolecular progression of WLS expression in serous ovarian cancer, from borderline (a), low-grade (b), high-grade (c), and metastatic (d) serous carcinomas (all at magnification × 40).